Search

Your search keyword '"C. Linch"' showing total 46 results

Search Constraints

Start Over You searched for: Author "C. Linch" Remove constraint Author: "C. Linch" Language english Remove constraint Language: english
46 results on '"C. Linch"'

Search Results

1. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients

2. Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial

3. Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study

4. Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial

5. Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment

6. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

7. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

8. Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes

9. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency

10. Favourable Outcomes for High-Risk Diffuse Large B-Cell Lymphoma (IPI 3-5) Treated with Front-Line R-CODOX-M/R-IVAC Chemotherapy: Results of a Phase 2 UK NCRI Trial

11. EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress

12. The effect of inhibition of leukotriene synthesis on the activity of interleukin-8 and granulocyte-macrophage colony-stimulating factor

13. Novel markers in pediatric-type follicular lymphoma

14. Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia

15. HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

16. Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma

17. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting

18. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor

19. Amplification of mitochondrial DNA in acute myeloid leukaemia

20. Assessment of minimal residual disease in standard-risk AML

21. ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial

22. A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report

23. Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

24. Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia

25. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

26. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

27. The effect of inhibition of leukotriene synthesis on the activity of interleukin-8 and granulocyte-macrophage colony-stimulating factor

28. Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication

29. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

30. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity

31. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

32. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

33. Hodgkin's lymphoma in adults

34. High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

35. Abnormalities of T-cell subsets in patients with neutropenia and an excess of lymphocytes in the bone marrow

36. Neutropenia, splenomegaly and high titre antinuclear antibody

37. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis

38. Immune guided missiles

39. Activation of human monocytes occurs on cross-linking monocytic antigens to an Fc receptor

40. Bone marrow processing and cryopreservation

41. Phenotypic analysis of fetal blood leucocytes: potential for prenatal diagnosis of immunodeficiency disorders

42. The effect of mitogenic lectins and monoclonal antibodies on intracellular free calcium concentration in human T-lymphocytes

43. Investigation of early T cell activation: analysis of the effect of specific antigen, interleukin 2 and monoclonal antibodies on intracellular free calcium concentration

45. Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia.

46. De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial.

Catalog

Books, media, physical & digital resources